INDIA
Alembic Pharma reports 11% revenue growth for Q4FY22, India business up 25%
When asked about the growth projections of the company in the next quarters, Pranav Amin, Managing Director, said it depends on how the market performs.
TRENDS
Truemeds aims to become household name for medicines at true prices: Founders
Truemeds, which raised $22 million last month, operates from Maharashtra, where it fulfils over 100,000 orders every month. The company aims to reach 500,000 monthly orders by March 2023.
INDIA
Pharma clocks best export performance ever in FY22: Government
Exports in 2021-22 sustained positive growth despite global trade disruptions and drop in demand for COVID medicines. Trade balance continues to be in India’s favour, with a surplus of $15175.81 million, the ministry said.
BUSINESS
Interview | Russia-Ukraine war piles stress on Indian pharma industry, says Sudarshan Jain of IPA
Indian drug makers should focus on raising the quality of their products to capture 5-6 percent of global pharma sales by 2030, says the secretary general of the Indian Pharmaceutical Alliance
TRENDS
Agatsa, world’s smallest ECG maker, eyes entry into US market next year
Electronics engineer Neha Rastogi and Rahul Rastogi said Agatsa is working with different agencies for US FDA clearances and CE validations because of the high demand for small ECG machines in the international markets.
INDIA
Exclusive: Supplied nearly 100 million doses to Govt; committed to meeting growing demand for Corbevax: Biological E’s COO
Data on the Omicron variant in children was not part of our clinical trial endpoints. We have submitted all the data generated against multiple variants to regulatory agencies including NTAGI. We are regularly making presentations to the regulatory bodies as more and more data gets generated, says Lakshminarayana Neti
TRENDS
Will wait for NTAGI’s nod before administering COVID-19 vaccine in 5-12 age group: Health Minister
When asked if the gap for taking the booster dose has been reduced from nine months to six, the minister said, NTAGI is the panel to take decisions in this regard.
INDIA
Hospital-based surveillance for sexually transmitted diseases to start in India: ICMR
The study’s objective is to examine the frequency, clinical laboratory features, antimicrobial resistance patterns and treatment outcomes related to STIs.
INDIA
Lupin partners Yabao to market paediatric products in China
"It paves the way for us to bring quality paediatric formulations to the growing needs of patients in China," Fabrice Egros, president - corporate development and growth markets, Lupin, said.
INDIA
ICMR scientist develops world’s first rapid, cost-effective kits to diagnose haemophilia, von Willebrand disease
This simple strip-based test can be performed at a Primary Healthcare Centre. It holds the potential to change the diagnostic landscape of bleeding disorders like haemophilia and von Willebrand disease (vWD), not only in India but in several other developing countries, which either lack proper diagnostic facilities or where existing facilities are not up to acceptable standards
TRENDS
Pharma CEOs urge Centre to rationalise prices of essential drugs
The National Pharmaceutical Pricing Authority (NPPA), from April, has allowed a price hike for scheduled drugs, which are under price control under the NLEM.
INDIA
Glenmark rolls out fixed dose combination for type two diabetes in India
Launched under the brand name Zita Plus Pio, the company said this drug contains Teneligliptin (20 mg) and Pioglitazone (15 mg) which can be taken once in a day.
INDIA
India cuts dependency on imported raw material for drugs by 25%: Minister Mandaviya
India reduced imports by encouraging local production of key bulk drugs and offering manufacturers financial incentives.
BUSINESS
WHO strongly recommends Pfizer’s Paxlovid for patients with non-severe COVID-19
Pfizer’s Paxlovid has been recommended over remdesivir and antiviral drug molnupiravir manufactured by Merck.
BUSINESS
COVID-19: 25 districts reporting over 10% weekly positivity, 14 from Kerala
Apart from Kerala, seven districts from Mizoram and one each from Haryana, Uttar Pradesh, Meghalaya, and Manipur are among the high case-contributing districts.
BUSINESS
No end in sight for India’s wait for Paxlovid, the most promising COVID-19 drug yet, despite surging cases
Late-stage clinical trials showed Paxlovid cut hospitalisation and death risks in mild to moderately high-risk COVID-19 patients by up to 88 percent and new evidence is emerging that it is also dramatically effective in treating long COVID symptoms
INDIA
Eighteen to fifty nine year olds least jabbed with boosters against virus, raising concerns at ministry
According to a top official, this group has the highest population and the least number of people have opted for booster doses in this category.
INDIA
New centre in Gujarat will maximise role of traditional medicine in global healthcare, says WHO regional director
Prime Minister Narendra Modi will on April 19 lay the foundation for the World Health Organisation (WHO) Global Centre for Traditional Medicine (GCTM) in Jamnagar, Gujarat
